PEPG
Biotechnology · Healthcare
CEO
2021-01-01–present
Equibles does not estimate personal net worth.
Get an email with a short summary when PepGen Inc. publishes a filing, an earnings call transcript or a press release.
Get PEPG alertsJames McArthur is recorded as CEO at PepGen Inc. (PEPG). The proxy statement of PepGen Inc. reports total compensation of $3,316,783 for James McArthur in fiscal 2025, including a base salary of $619,000. Disclosed compensation is on record for 5 fiscal years. James McArthur has spoken on 1 earnings call across 1 company, most recently for PepGen Inc. on March 6, 2024. PepGen Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at PepGen Inc. includes Noel Donnelly (CFO), Mary Beth DeLena (General Counsel), Habib J. Dable (Board Member) and 4 others.
“PepGen made meaningful progress over the course of 2023, including the initiation of our first inpatient clinical trials evaluating programs derived from PepGen Enhanced Delivery Oligonucleotide, or EDO, cell-penetrating peptide platform in two neuromuscular diseases with high unmet medical need.”
2021-01-01–2024-04-26
Last confirmed by a filing; no departure on record
PEPG
Biotechnology · Healthcare
CEO
2021-01-01–present
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | PepGen Inc. (PEPG) | President and Chief Executive Officer | $619,000 | $3,316,783 |
| 2024 | PepGen Inc. (PEPG) | President and Chief Executive Officer | $594,880 | $4,426,218 |
| 2023 | PepGen Inc. (PEPG) | President and Chief Executive Officer | $572,000 | $3,425,703 |
| 2022 | PepGen Inc. (PEPG) | President and Chief Executive Officer | $522,333 | $4,511,477 |
| 2021 | PepGen Inc. (PEPG) | President and Chief Executive Officer | $407,604 | $4,088,874 |